Sign In
Buy AMD
$483.36
-5.92 (-1.21%)
At Close: Aug 07, 2026
AMD Rides on Accelerating Data Center Growth: A Sign of More Upside?
02:35pm, Tuesday, 02'nd Sep 2025
AMD's surging EPYC adoption, cloud wins, and Instinct GPU traction fuel strong Data Center growth despite AI export headwinds.
Why this analyst says skip Nvidia but play these 3 chip stocks
06:00am, Sunday, 31'st Aug 2025
Semiconductors are driving the future of tech, but which companies are worth watching other than Nvidia (NVDA)? Ali Mogharabi, senior equity analyst at WestEnd Capital Management, discusses his top ch
3 Red-Hot Growth Stocks to Buy in 2025
04:55am, Saturday, 30'th Aug 2025
The hottest area of growth in the market is artificial intelligence (AI). This is being led by big tech companies, which continue to see strong demand stemming from AI.
3 Stocks That Beat Bitcoin in 2025
03:16pm, Friday, 29'th Aug 2025
It's been a banner year, so far, for cryptocurrency enthusiasts worldwide. Bitcoin (CRYPTO:BTC), the world's most popular cryptocurrency, touched an all-time high of $124,457.12 in mid-August before
AMD's AI Journey Rides on Strong Partner Base: What's the Path Ahead?
12:52pm, Friday, 29'th Aug 2025
AMD's expanding partner base, strong EPYC demand, and new AI collaborations fuel growth despite stiff competition from NVIDIA and Broadcom.
AMD: There Is Still Time To Accumulate Shares
10:49am, Friday, 29'th Aug 2025
I reiterate my Strong Buy rating for Advanced Micro Devices, Inc., as the market is finally recognizing its AI potential and undervalued stock price. AMD's AI accelerators and EPYC CPUs are gaining tr
Taking Profits For Yield And Growth With David Alton Clark
05:00pm, Thursday, 28'th Aug 2025
David Alton Clark, The Winter Warrior Investor, thinks the market is a little bit toppy with stretched valuations. Focusing on high-conviction positions, trimming the number of holdings, and reallocat
Outlook Therapeutics plunges more than 52% after FDA rejects wet AMD drug
11:51am, Thursday, 28'th Aug 2025
Shares of Outlook Therapeutics fell sharply on Thursday after the US Food and Drug Administration (FDA) rejected the company's application for its experimental eye drug ONS-5010, a proposed treatment
AMD stock rallies above $170 with bullish analyst calls: should you buy?
10:17am, Thursday, 28'th Aug 2025
AMD stock jumped over 2% on Thursday, climbing above $170 as a wave of good news got investors excited about the chipmaker again.
NVDA, INTC and AMD Forecast – Chip Stocks Mixed After Nvidia Earnings
08:53am, Thursday, 28'th Aug 2025
The huge Nvidia earnings call has come and gone, and now it looks like the market is trying to sort out whether or not we can continue higher in most of these microchip stocks.
ISELIN, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of re
Broadcom, AMD, Micron Other Chip Stocks Fell After Nvidia Earnings. What They're Doing Now.
06:13am, Thursday, 28'th Aug 2025
Broadcom, AMD and Micron stocks fell in after-hours trading as the market focused on Nvidia missing expectations for its vital data-center segment.
NVDA, AMD and INTC Forecast – Major Tech Stocks Wait for NVDA Earnings
08:41am, Wednesday, 27'th Aug 2025
The three stocks in this analysis are all waiting for the Nvidia earnings at the end of the day, as it will dictate where the overall risk appetite of the indices will fall. The “knock on effect”
Wall Street sets Nvidia and AMD price targets for next 12 months
06:51am, Wednesday, 27'th Aug 2025
The day of Nvidia's (NASDAQ: NVDA) next quarterly earnings report has arrived, and the market expectations could not be higher.
Will AMD Be a $1 Trillion Company by 2030?
06:00am, Wednesday, 27'th Aug 2025
AMD (AMD 2.03%) is one of the primary tech giants competing in the artificial intelligence (AI) arms race. While AMD has a significantly smaller market share than best-in-class Nvidia (NVDA 1.10%), it
